エンジニアードT細胞のアジア市場：市場規模・シェア・価格・動向・予測

• 英文タイトル：Asia Pacific Engineered T Cells Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

• レポートコード：D0FB0642807 • 出版社/出版日：Prof Research / 2019年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥420,000 (USD3,000)	▷ お問い合わせ
Site License	￥532,000 (USD3,800)	▷ お問い合わせ
Global Site License	￥700,000 (USD5,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

エンジニアードT細胞のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はエンジニアードT細胞の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおけるエンジニアードT細胞市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。 ・市場概要 ・産業チェーン分析（ファイブフォース分析、コスト構造分析） ・市場動向 ・エンジニアードT細胞のアジア市場規模推移2014-2019 ・エンジニアードT細胞のアジア市場規模予測2019-2024 ・エンジニアードT細胞のサプライヤー分析 ・顧客（需要先）分析 ・主要企業分析（Autolus Limited、Bellicum Pharmaceuticals、Cells Medica、Elli Lilly and Company、Gilead Sciences、Juno Therapeutics、Novartis、Oxford Biomedica、Pfizer、Precision Bioscience、Redmile Group、Seeking Al） ・結論

Abstract:

The Asia Pacific Engineered T Cells market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Engineered T Cells market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Engineered T Cells market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Engineered T Cells
* It describes present situation, historical background and future forecast
* Comprehensive data showing Engineered T Cells capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Engineered T Cells manufacturers
* Engineered T Cells market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Engineered T Cells market: (At least 12 companies included)
* Autolus Limited
* Bellicum Pharmaceuticals
* Cells Medica
* Elli Lilly and Company
* Gilead Sciences
* Juno Therapeutics
For complete list, please ask for sample pages.

The Engineered T Cells market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Engineered T Cells market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Engineered T Cells market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

---

Table of Contents

Chapter One Engineered T Cells Overview
1.1 Engineered T Cells Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Engineered T Cells Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Engineered T Cells (2014-2019)
4.1 Engineered T Cells Supply
4.2 Engineered T Cells Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Engineered T Cells Supply
5.2 Engineered T Cells Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Engineered T Cells Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Autolus Limited
8.2 Bellicum Pharmaceuticals
8.3 Cells Medica
8.4 Elli Lilly and Company
8.5 Gilead Sciences
……
……

Chapter Nine Research Conclusions of Asia Pacific Engineered T Cells Industry

Tables and Figures

Figure Commercial Product of Engineered T Cells
Table Classification of Engineered T Cells
Table Application of Engineered T Cells
Figure Porter Five Forces Model Analysis of Asia Pacific Engineered T Cells
Figure Production Cost Analysis of Asia Pacific Engineered T Cells
Table Engineered T Cells Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Engineered T Cells Capacity List
Table 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production List
Table 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Engineered T Cells Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Engineered T Cells Production Value and Growth Rate
Table 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Engineered T Cells Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Engineered T Cells
Table 2014-2019 Asia Pacific Import and Export of Engineered T Cells
Table 2014-2019 Asia Pacific Engineered T Cells Demand List by Application
Figure 2014-2019 Asia Pacific Engineered T Cells Demand by Application
Table 2014-2019 Asia Pacific Engineered T Cells Demand Share List by Application
Figure 2014-2019 Asia Pacific Engineered T Cells Demand Share by Application
Table 2014-2019 Asia Pacific Engineered T Cells Country-wise Consumption List
Figure 2014-2019 Asia Pacific Engineered T Cells Country-wise Consumption
Table 2014-2019 Asia Pacific Engineered T Cells Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Engineered T Cells Country-wise Consumption Share
Table 2014-2019 Asia Pacific Engineered T Cells Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Engineered T Cells Capacity List
Table 2019-2024 Asia Pacific Engineered T Cells Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Engineered T Cells Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Engineered T Cells Key Manufacturers Production List
Table 2019-2024 Asia Pacific Engineered T Cells Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Engineered T Cells Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Engineered T Cells Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Engineered T Cells Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Engineered T Cells
Table 2019-2024 Asia Pacific Import and Export of Engineered T Cells
Table 2019-2024 Asia Pacific Demand of Engineered T Cells by Application
Figure 2019-2024 Asia Pacific Engineered T Cells Demand by Application
Table 2019-2024 Asia Pacific Engineered T Cells Demand Share List by Application
Figure 2019-2024 Asia Pacific Engineered T Cells Demand Share by Application
Table 2019-2024 Asia Pacific Engineered T Cells Country-wise Consumption List
Figure 2019-2024 Asia Pacific Engineered T Cells Country-wise Consumption
Table 2019-2024 Asia Pacific Engineered T Cells Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Engineered T Cells Country-wise Consumption Share
Table 2019-2024 Asia Pacific Engineered T Cells Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Engineered T Cells Raw Material Suppliers
Table Key End Users List
Table Profile of Autolus Limited
Table SWOT Analysis of Autolus Limited
Table Autolus Limited Engineered T Cells Product Specification
Table 2014-2019 Autolus Limited Engineered T Cells Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Autolus Limited Engineered T Cells Capacity Production and Growth Rate
Figure 2014-2019 Autolus Limited Engineered T Cells Production Global Market Share
Table SWOT Analysis of Bellicum Pharmaceuticals
Figure Bellicum Pharmaceuticals Engineered T Cells Products
Table 2014-2019 Bellicum Pharmaceuticals Engineered T Cells Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bellicum Pharmaceuticals Engineered T Cells Capacity Production and Growth Rate
Figure 2014-2019 Bellicum Pharmaceuticals Engineered T Cells Production Global Market Share
Table SWOT Analysis of Cells Medica
Figure Cells Medica Engineered T Cells Product
Table Cells Medica Engineered T Cells Product Specification
Table 2014-2019 Cells Medica Engineered T Cells Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Cells Medica Engineered T Cells Capacity Production and Growth Rate
Figure 2014-2019 Cells Medica Engineered T Cells Production Global Market Share
Table Profile of Elli Lilly and Company
Table SWOT Analysis of Elli Lilly and Company
Figure Elli Lilly and Gilead Sciencesngineered T Cells Product
Table Elli Lilly and Gilead Sciencesngineered T Cells Product Specification
Table 2014-2019 Elli Lilly and Gilead Sciencesngineered T Cells Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Elli Lilly and Gilead Sciencesngineered T Cells Capacity Production and Growth Rate
Figure 2014-2019 Elli Lilly and Gilead Sciencesngineered T Cells Production Global Market Share
Table Profile of Gilead Sciences
Table SWOT Analysis of Gilead Sciences
Figure Gilead Sciences Engineered T Cells Product
Table 2014-2019 Gilead Sciences Engineered T Cells Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Gilead Sciences Engineered T Cells Capacity Production and Growth Rate
Figure 2014-2019 Gilead Sciences Engineered T Cells Production Global Market Share
……
……

---